Cardiovascular disease including myocardial infarction in men aged 45 to 65. Ischemic heart diseases (I20–I25)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Middle-aged men (45-65 years) with myocardial infarction Physician’s approval for participation in the exercise program Non-smokers No alcohol consumption
Exclusion criteria
Exclusion criteria: Presence of warning signs during exercise Unstable angina pectoris Dyspnea at rest or severe arrhythmias Chronic diseases causing discomfort during exercise ST segment elevation or depression on ECG during exercise Respiratory disturbances during exercise Inability or unwillingness to complete the exercise program
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcomes include changes in systolic and diastolic blood pressure, resting heart rate, left ventricular ejection fraction, and cardiac capacity and performance as assessed by stress testing, measured before and after the 8-week intervention. Timepoint: Primary outcome variables will be measured at two time points: baseline (before the intervention) and immediately after the 8-week exercise program. Method of measurement: Systolic Blood Pressure: Measured using a blood pressure monitor in mmHg.Diastolic Blood Pressure: Measured using a blood pressure monitor in mmHg.Resting Heart Rate: Measured by counting heartbeats per minute at rest.Left Ventricular Systolic Function: Calculated by echocardiography using ejection fraction (stroke volume/end-diastolic volume).Cardiac Capacity and Performance: Assessed using a cardiac stress test (exercise test). | — |
Countries
Iran (Islamic Republic of)
Contacts
Kharazmi University